Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novo Nordisk Research Center Gladsaxe ApS
APS
Active
Advertising protection
CVR 39119374
Novo Alle 1, 2880
Bagsværd
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2017 · 8 years old
7 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Novo Nordisk Research Center Gladsaxe ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
RR
Rikke Ryttergaard Andersen
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
CT
Casper Tind Hansen
Chief Executive Officer
Chief Executive Officer
2017 – 2023
JB
Jakob Bondo Hansen
Management
Management
2021 – 2023
TH
Trine Haastrup
Management
Management
2023 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KA
Kristine Aachmann Bethe
Board of Directors
2023
PB
Peter Bøggild
Chairman
2023
Former (1)
KC
Klaus Christian Schollmeier
Chairman
2021 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NOVO NORDISK A/S
Company
100%
100%
2023
Gerhart-Hines Holding ApS
Company
25–33.32%
25–33.32%
2017
Embark Holdings ApS
Company
90–99.99%
90–99.99%
2023
Bondo Hansen Holding ApS
Company
25–33.32%
25–33.32%
2017
Receptor Holding ApS
Company
25–33.32%
25–33.32%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Novo Nordisk Research Center Gladsaxe ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
